Not applicableStudy completedNCT01771562What this trial is testingNutritional and Metabolic Disorders in HIV Infected Children and AdolescentWho this might be right forHIV-1 ANRS, Emerging Infectious Diseases 330
Large-scale testing (Phase 3)Study completedNCT03802240What this trial is testingSintilimab ± IBI305 Plus Chemotherapy (Pemetrexed + Cisplatin) for EGFRm + Locally Advanced or Metastasis Non-Squamous NSCLC Patients After EGFR-TKI Treatment FailureWho this might be right forNon-Squamous Non-Small Cell Lung Cancer Innovent Biologics (Suzhou) Co. Ltd. 492
Large-scale testing (Phase 3)Ended earlyNCT02996760What this trial is testingInfluence Instillation Plasma Rich in Growth Factors in Endometrial Cavity Endometrial Development in Assisted Reproduction.Who this might be right forEndometrial Development IVI Bilbao 22
Not applicableStudy completedNCT02884791What this trial is testingFGF21 and Fructose Challenge in HumansWho this might be right forFasting Beth Israel Deaconess Medical Center 50
Testing effectiveness (Phase 2)Looking for participantsNCT05886920What this trial is testingD3S-002 as Monotherapy or Combination Therapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway MutationsWho this might be right forAdvanced Solid Tumors With MAPK Pathway Mutations D3 Bio (Wuxi) Co., Ltd 67
Testing effectiveness (Phase 2)WithdrawnNCT04781374What this trial is testingNeratinib in Patients With Metastatic Castration-Resistant Prostate CancerWho this might be right forMetastatic Prostate AdenocarcinomaCastration-resistant Prostate CancerProstate Cancer+1 more Beth Israel Deaconess Medical Center
Not applicableUnknownNCT01317888What this trial is testingAccess Protocol for MAB-425 Radiolabeled With I-125 for High Grade GliomasWho this might be right forGlioblastoma MultiformeAstrocytoma Anaplastic Foci Drexel University 11
Early research (Phase 1)Ended earlyNCT04691375What this trial is testingPY314 in Subjects With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorGynecologic CancerBreast Cancer+6 more Ikena Oncology 86
Testing effectiveness (Phase 2)Study completedNCT00627536What this trial is testingScar-Improvement Efficacy and Safety of a Single Intradermal Injection of Avotermin (Juvista) Administered Following Full-Thickness Skin IncisionsWho this might be right forCicatrix Renovo 39
Testing effectiveness (Phase 2)Looking for participantsNCT07070232What this trial is testingA Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant TumorsWho this might be right forAdvanced Solid Tumor BioNTech SE 1,438
Testing effectiveness (Phase 2)WithdrawnNCT00048087What this trial is testingIressa/Docetaxel in Non-Small-Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)UnknownNCT01249521What this trial is testingDual Targeting of Vascular Endothelial Growth Factor-A Together With Angiopoietins in Chemotherapy-naïve Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Austin Health 40
Testing effectiveness (Phase 2)WithdrawnNCT01288092What this trial is testingBEZ235 Trial in Patients With HER2-(Human Epidermal Growth Factor Receptor 2 Negative) /HR+ (Hormonal Receptor Positive) Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Novartis Pharmaceuticals
Large-scale testing (Phase 3)Ended earlyNCT03656536What this trial is testingEvaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic CholangiocarcinomaWho this might be right forUnresectable CholangiocarcinomaMetastatic Cholangiocarcinoma Incyte Corporation 167
Large-scale testing (Phase 3)Active Not RecruitingNCT05870319What this trial is testingA Phase III Study of SKB264 for EGFR Mutant NSCLC PatientsWho this might be right forNon-small Cell Lung Cancer Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 376
Post-approval studies (Phase 4)WithdrawnNCT01891500What this trial is testingEarly iNO for Oxidative Stress, Vascular Tone and Inflammation in Babies With Hypoxic Respiratory FailureWho this might be right forPersistent Fetal Circulation SyndromeHypertension, Pulmonary, of Newborn, PersistentPersistent Pulmonary Hypertension of Newborn University of Florida
Large-scale testing (Phase 3)Looking for participantsNCT07062965What this trial is testingLearn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.Who this might be right forBreast Cancer Pfizer 400
Not applicableActive Not RecruitingNCT03651505What this trial is testingX-linked Hypophosphatemia Disease Monitoring ProgramWho this might be right forX-linked HypophosphatemiaHypophosphatemic Rickets Ultragenyx Pharmaceutical Inc 782
Large-scale testing (Phase 3)Looking for participantsNCT07071337What this trial is testingSKB264 Versus Investigator's Choice of Chemotherapy in Subjects With Unresectable Locally Advanced, Relapsed, or Metastatic HR+/HER2- Breast Cancer Who Have Previously Failed Endocrine TherapyWho this might be right forMetastatic Breast Cancer Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 430
Large-scale testing (Phase 3)Study completedNCT00637377What this trial is testingVascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD)Who this might be right forMacular Degeneration Bayer 1,240